Showing results (321-330 of 383) with videos related to
Sort By:
Pageof 39
Journal of Cardiovascular Pharmacology|November 22, 2007
Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrelChristopher D Payne, Ying Grace Li, David S Small, et al.American Heart Journal|November 1, 1989
Acute and sustained release of atrial natriuretic factor with acute myocardial infarctionL Ngo, D L Vesely, J K Bissett, et al.British Journal of Clinical Pharmacology|November 23, 2012
A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivityJoseph A Jakubowski, Chunmei Zhou, David S Small, et al.Stroke|February 18, 2016
Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS TrialChee Tang Chin, Benjamin Neely, E Magnus Ohman, et al.Thrombosis and Haemostasis|June 29, 2007
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinAndrew L Frelinger, Joseph A Jakubowski, Youfu Li, et al.Proceedings of the National Academy of Sciences of the United States of America|June 13, 2023
Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypesYi Sun, Michael C Young, Claire H Woodward, et al.Circulation|November 18, 2014
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placementKirk N Garratt, W Douglas Weaver, Ronald G Jenkins, et al.Journal of Cardiovascular Pharmacology|January 27, 2011
The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology dataBaojin Zhu, Mark B Effron, M Pandurang Kulkarni, et al.Platelets|July 29, 2009
Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjectsYing G Li, Lan Ni, John T Brandt, et al.Thrombosis Research|July 16, 2014
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER studyJoseph A Jakubowski, Dominick J Angiolillo, Chunmei Zhou, et al.Pageof 39